Ente Ospedaliero Cantonale, Bellinzona
Clinical trials sponsored by Ente Ospedaliero Cantonale, Bellinzona, explained in plain language.
-
MS patients may benefit from switching Immune-Suppressing drugs
Disease control OngoingThis study looks at whether switching from anti-CD20 drugs (like ocrelizumab) to cladribine can help restore immune function and reduce infections in people with relapsing multiple sclerosis. About 70 participants will be followed for 2 years. The goal is to see if the switch imp…
Sponsor: Ente Ospedaliero Cantonale, Bellinzona • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New combo therapy aims to ease knee arthritis pain without surgery
Symptom relief OngoingThis study tests whether adding blood flow restriction (a technique that gently limits blood flow to the legs) to walking on an anti-gravity treadmill can better reduce pain and improve function in people with knee osteoarthritis. About 70 adults aged 45-80 with knee arthritis wi…
Phase: NA • Sponsor: Ente Ospedaliero Cantonale, Bellinzona • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC